Effect of a novel IL-2 cytokine immune agonist (NKTR-214) on proliferating CD8+T cells and PD-1 expression on immune cells in the tumor microenvironment in patients with prior checkpoint therapy.

Chantale Bernatchez, Adi Diab, Michael E. Hurwitz et al.|Journal of Clinical Oncology|2017

Cited by 23